Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS)

Metabolism: Clinical and Experimental

Volumn 63, Issue 9, 2014, Pages 1093-1103

  Kuwashiro, Takahiro ^a,b   Ago, Tetsuro ^a   Kamouchi, Masahiro ^a   Matsuo, Ryu ^a   Hata, Jun ^a   Kuroda, Junya ^a   Fukuda, Kenji ^c   Sugimori, Hiroshi ^a   Fukuhara, Masayo ^a   Awano, Hideto ^d   Isomura, Tetsu ^d   Suzuki, Kazuo ^d   Yasaka, Masahiro ^b   Okada, Yasushi ^b   Kiyohara, Yutaka ^a   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c ST MARY S HOSPITAL   (Japan)

^d Molecuence Corporation   (Japan)

Author keywords

Adiponectin; Biomarkers; Functional outcome; Ischemic stroke; Stroke subtype

Indexed keywords

ADIPONECTIN;

AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTICENTER STUDY (TOPIC); NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; NORMAL VALUE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE; STROKE PATIENT;

ADIPONECTIN; BIOMARKERS; FUNCTIONAL OUTCOME; ISCHEMIC STROKE; STROKE SUBTYPE;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; STROKE; STROKE, LACUNAR;

EID: 84906222971     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.04.012     Document Type: Article

References (49)

1. G.A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg Association of adiponectin with coronary heart disease and mortality: The rancho bernardo study Am J Epidemiol 165 2007 164 174
2. E.P. Neale, B. Muhlhausler, Y.C. Probst, M.J. Batterham, F. Fernandez, and L.C. Tapsell Short-term effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults Metabolism 62 2013 651 660
3. K. Rabe, M. Lehrke, K.G. Parhofer, and U.C. Broedl Adipokines and insulin resistance Mol Med 14 2008 741 751
4. B. Chen, W.Q. Liao, N. Xu, H. Xu, J.Y. Wen, and C.A. Yu et al. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action Brain Res 1273 2009 129 137
5. M. Nishimura, Y. Izumiya, A. Higuchi, R. Shibata, J. Qiu, and C. Kudo et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms Circulation 117 2008 216 223
6. S.N. Rajpathak, R.C. Kaplan, S. Wassertheil-Smoller, M. Cushman, T.E. Rohan, and A.P. McGinn et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: Results from the women's health initiative Stroke 42 2011 1813 1820
7. N. Sattar, G. Wannamethee, N. Sarwar, J. Tchernova, L. Cherry, and A.M. Wallace et al. Adiponectin and coronary heart disease: A prospective study and meta-analysis Circulation 114 2006 623 629
8. J. Frystyk, C. Berne, L. Berglund, K. Jensevik, A. Flyvbjerg, and B. Zethelius Serum adiponectin is a predictor of coronary heart disease: A population-based 10-year follow-up study in elderly men J Clin Endocrinol Metab 92 2007 571 576
9. Q. Li, Y. Lu, L. Sun, J. Yan, X. Yan, and L. Fang et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease Metabolism 61 2012 1803 1808
10. C. Savopoulos, K. Michalakis, M. Apostolopoulou, A. Miras, and A. Hatzitolios Adipokines and stroke: A review of the literature Maturitas 70 2011 322 327
11. M.P. Chen, J.C. Tsai, F.M. Chung, S.S. Yang, L.L. Hsing, and S.J. Shin et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease Arterioscler Thromb Vasc Biol 25 2005 821 826
12. M. Matsumoto, S. Ishikawa, and E. Kajii Association of adiponectin with cerebrovascular disease: A nested case-control study Stroke 39 2008 323 328
13. P. Khalili, A. Flyvbjerg, J. Frystyk, F. Lundin, J. Jendle, and G. Engstrom et al. Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study Diabetes Metab 36 2010 137 143
14. M. Kamouchi, T. Matsuki, J. Hata, T. Kuwashiro, T. Ago, and Y. Sambongi et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: The fukuoka stroke registry Stroke 42 2011 2788 2794
15. T. Kuwashiro, H. Sugimori, T. Ago, M. Kamouchi, and T. Kitazono Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: The fukuoka stroke registry Cerebrovasc Dis 33 2012 141 149
16. J. Hata, Y. Tanizaki, Y. Kiyohara, I. Kato, M. Kubo, and K. Tanaka et al. Ten year recurrence after first ever stroke in a japanese community: The hisayama study J Neurol Neurosurg Psychiatry 76 2005 368 372
17. Special report from the national institute of neurological disorders and stroke Classification of cerebrovascular diseases iii Stroke 21 1990 637 676
18. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment Stroke 24 1993 35 41
19. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a who consultation Diabet Med 15 1998 539 553
20. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin et al. Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement Circulation 112 2005 2735 2752
21. E. Oda, K. Oohara, A. Abe, P.T. Veeraveedu, K. Watanabe, and K. Kato et al. The optimal cut-off point of c-reactive protein as an optional component of metabolic syndrome in Japan Circ J 70 2006 384 388
22. A.D. Ogorodnikova, S. Wassertheil-Smoller, P. Mancuso, M.R. Sowers, S.N. Rajpathak, and M.A. Allison et al. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women. A women's health initiative study Stroke 41 2010 1376 1381
23. F. Liu, Z. He, S. Deng, H. Zhang, N. Li, and J. Xu Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a chinese han population Mol Biol Rep 38 2011 1983 1988
24. Y. Yamada, K. Kato, M. Oguri, T. Yoshida, K. Yokoi, and S. Watanabe et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome Int J Mol Med 21 2008 801 808
25. H.H. Hegener, I.M. Lee, N.R. Cook, P.M. Ridker, and R.Y. Zee Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: A nested case-control study Clin Chem 52 2006 2021 2027
26. M. Shimabukuro, N. Higa, T. Asahi, Y. Oshiro, N. Takasu, and T. Tagawa et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man J Clin Endocrinol Metab 88 2003 3236 3240
27. N. Ouchi, M. Ohishi, S. Kihara, T. Funahashi, T. Nakamura, and H. Nagaretani et al. Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
28. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 2006 1784 1792
29. Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, and M. Kumada et al. Adiponectin reduces atherosclerosis in apolipoprotein e-deficient mice Circulation 106 2002 2767 2770
30. T. Nakamura, H. Funayama, N. Kubo, T. Yasu, M. Kawakami, and M. Saito et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure Circ J 70 2006 1557 1562
31. M. Shimano, R. Shibata, Y. Tsuji, H. Kamiya, T. Uchikawa, and S. Harata et al. Circulating adiponectin levels in patients with atrial fibrillation Circ J 72 2008 1120 1124
32. H. Nagasawa, C. Yokota, K. Toyoda, A. Ito, and K. Minematsu High level of plasma adiponectin in acute stroke patients is associated with stroke mortality J Neurol Sci 304 2011 102 106
33. K. Yatomi, N. Miyamoto, M. Komine-Kobayashi, M. Liu, H. Oishi, and H. Arai et al. Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain Brain Res 1297 2009 169 176
34. R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling J Biol Chem 279 2004 28670 28674
35. H. Kobayashi, N. Ouchi, S. Kihara, K. Walsh, M. Kumada, and Y. Abe et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 2004 e27 e31
36. C. Kistorp, J. Faber, S. Galatius, F. Gustafsson, J. Frystyk, and A. Flyvbjerg et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
37. S. Pilz, R. Horejsi, R. Moller, G. Almer, H. Scharnagl, and T. Stojakovic et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin J Clin Endocrinol Metab 90 2005 4792 4796
38. V. Menon, L. Li, X. Wang, T. Greene, V. Balakrishnan, and M. Madero et al. Adiponectin and mortality in patients with chronic kidney disease J Am Soc Nephrol 17 2006 2599 2606
39. M. Matsuda, I. Shimomura, M. Sata, Y. Arita, M. Nishida, and N. Maeda et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis J Biol Chem 277 2002 37487 37491
40. F. Lopez-Jimenez, S.J. Jacobsen, G.S. Reeder, S.A. Weston, R.A. Meverden, and V.L. Roger Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community Chest 125 2004 1205 1212
41. M. Apostolopoulou, C. Savopoulos, K. Michalakis, S. Coppack, T. Dardavessis, and A. Hatzitolios Age, weight and obesity Maturitas 71 2012 115 119
42. K. Vemmos, G. Ntaios, K. Spengos, P. Savvari, A. Vemmou, and T. Pappa et al. Association between obesity and mortality after acute first-ever stroke: The obesity-stroke paradox Stroke 42 2011 30 36
43. T. Ahonen, M. Vanhala, H. Kautiainen, E. Kumpusalo, and J. Saltevo Sex differences in the association of adiponectin and low-grade inflammation with changes in the body mass index from youth to middle age Gender medicine 9 2012 1 8
44. J. Persson, L. Folkersen, J. Ekstrand, J. Helleberg, A. Gabrielsen, and P. Lundman et al. High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis Atherosclerosis 225 2012 491 496
45. B. Baranowska, J. Kochanowski, M. Grudniak, A. Baranowska-Bik, E. Wolinska-Witort, and L. Martynska et al. Decreased total serum adiponectin and its isoforms in women with acute ischemic stroke Neuro endocrinology letters 32 2011 711 715
46. M. Sasaki, T. Kawano, T. Saito, M. Yuzawa, A. Ikoma, and H. Tamemoto et al. Hypoadiponectinemia in patients with cerebral infarction: Comparison with other atherosclerotic disorders Am J Med Sci 333 2007 140 144
47. S. Marousi, G. Theodorou, M. Karakantza, P. Papathanasopoulos, and J. Ellul Serum adiponectin acutely after an ischemic stroke: Implications for a long-lasting, suppressed anti-inflammatory role Acta Neurol Scand 121 2010 277 284
48. Y. Saisho, H. Hirose, R. Roberts, T. Abe, H. Kawabe, and H. Itoh C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the japanese general population: A longitudinal cohort study PloS one 8 2013 e73430
49. M.R. Ruth, A.M. Port, M. Shah, A.C. Bourland, N.W. Istfan, and K.P. Nelson et al. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers c-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects Metabolism 62 2013 1779 1787